BeyondSpring Inc.
(NASDAQ : BYSI)

( )
BYSI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.46%44.570.9%$933.06m
JNJJohnson & Johnson
2.11%139.440.6%$907.00m
MRKMerck & Co., Inc.
0.81%71.800.6%$601.93m
LLYEli Lilly and Company
2.29%113.571.0%$528.31m
ABBVAbbVie, Inc.
0.33%92.212.2%$497.27m
BMYBristol-Myers Squibb Company
1.85%58.901.4%$359.83m
NVSNovartis AG Sponsored ADR
-0.44%85.340.2%$182.89m
AZNAstraZeneca PLC Sponsored ADR
0.56%39.301.3%$155.01m
NVONovo Nordisk A/S Sponsored ADR Class B
0.23%43.490.1%$88.11m
GSKGlaxoSmithKline plc Sponsored ADR
-0.15%39.740.2%$87.95m
SNYSanofi Sponsored ADR
0.77%44.690.2%$59.78m
LCILannett Company, Inc.
-0.96%4.1237.0%$6.82m
AKTXAkari Therapeutics Plc Sponsored ADR
9.09%1.921.7%$0.17m
EPIXESSA Pharma Inc
-4.94%3.710.1%$0.04m

Company Profile

BeyondSpring, Inc. is a clinical stage company, which engages in the development of cancer therapies. It focuses on non-small cell lung cancer, neutropenia prevention, and plinabulin and nivolumab. The company was founded by Lan Huang and Lin Qing Jia in 2013 and is headquartered in New York, NY.